BPG is committed to discovery and dissemination of knowledge
Articles in Press
5/23/2022 1:08:19 AM | Browse: 112 | Download: 128
Category |
Infectious Diseases |
Manuscript Type |
Minireviews |
Article Title |
COVID-19 vaccination and myocarditis: A review of current literature
|
Manuscript Source |
Invited Manuscript |
All Author List |
Kartik Dhaduk, Jagjit Khosla, Muzna Hussain, Vrunda Mangaroliya, Shaylika Chauhan, Kumar Ashish, Rahul Gupta and Suman Pal |
Funding Agency and Grant Number |
|
Corresponding Author |
Kartik Dhaduk, MD, Staff Physician, Department of Internal Medicine, Geisinger Wyoming Valley Medical Center, 1000 E Mountain Dr, Wilkes-Barre, PA 18702, United States. kartikdhaduk@gmail.com |
Key Words |
Coronavirus disease 2019 vaccine; Myocarditis; mRNA vaccine; Severe acute respiratory syndrome coronavirus-2; Coronavirus disease 2019; Vaccine complications; Risk assessment |
Core Tip |
Coronavirus disease 2019 (COVID-19) vaccination campaign is progressing successfully, and more than 400 million vaccine doses have been administered in the United States. We support the COVID-19 vaccination drive given positive data on preventing significant morbidities from COVID-19 disease in fully vaccinated people and relatively rare occurrences of serious side effects. Many questions remain open such as: whether patients with a history of vaccine-associated myocarditis should receive the subsequent vaccines or booster doses, the long-term effect of vaccine-associated myocarditis, how to identify the high-risk individuals for such adverse reactions to selectively save vulnerable populations, etc. There is still substantial research to be done in this direction to answer unsolved questions. |
Citation |
Dhaduk K, Khosla J, Hussain M, Mangaroliya V, Chauhan S, Ashish K, Gupta R, Pal S. COVID-19 vaccination and myocarditis: A review of current literature. World J Virol 2022; 11(4): 170-175 |
|
Received |
|
2021-12-24 06:54 |
|
Peer-Review Started |
|
2021-12-24 06:55 |
|
To Make the First Decision |
|
|
|
Return for Revision |
|
2022-03-07 09:13 |
|
Revised |
|
2022-03-25 02:21 |
|
Second Decision |
|
2022-05-19 03:10 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Company Editor-in-Chief |
|
2022-05-23 01:08 |
|
Articles in Press |
|
2022-05-23 01:08 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2022-07-15 08:10 |
ISSN |
2220-3249 (online) |
Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
Copyright |
© The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved. |
Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
Website |
http://www.wjgnet.com |
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345